Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid?

Journal of Human Hypertension

Volumn 11, Issue 4, 1997, Pages 213-220

  Marques Vidal, P ^a   Tuomilehto, J ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Control; Population; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; COMMUNITY CARE; DEVELOPING COUNTRY; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; INDUSTRIALIZATION; PRIMARY PREVENTION; SCREENING; SEX DIFFERENCE;

EID: 0030946960     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000426     Document Type: Article

References (78)

1. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialised countries since 1950. Wld Hlth Statist Quart 1988; 41: 155-178.
2. Martin MJ et al. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet 1986; II: 933-936.
3. Medical Research Council Working Party. MRC trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-412.
4. Neaton JD et al. Treatment of Mild Hypertension Study. Final results. JAMA 1993; 270: 713-724.
5. Dollery C. Hypertension trial results: consensus and conflicts. J Hum Hypertens 1995; 9: 403-408.
6. WHO Technical Report Series. Prevention of coronary heart disease: Report of a WHO Expert Committee. In: WHO, 1982.
7. Tuomilehto J et al. Community programme for control of hypertension in North Karelia, Finland. Lancet 1980; II: 900-904.
8. Wilber JA, Barrow JG. Hypertension - a community problem. Am J Med 1972; 52: 653-663.
9. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. Br Med 1990; 300: 981-983.
10. Jackson RT, Beaglehole R, Stewart AW. Blood pressure levels and the treatment of hypertension in Auckland, 1982. NZ Med J 1983; 96: 751-754.
11. Fouriaud C et al. Influence of socioprofessional conditions on blood pressure levels and hypertension control. Am J Epidemiol 1984; 120: 72-86.
12. Radice M et al. Long-term efficacy of screening for hypertension in a community. J Hypertens 1985; 3: 255-259.
13. Huang YY. Prevalence and unawareness of hypertension in the petrochemical industrial population in China. Prev Med 1986; 15: 643-651.
14. Birkett NJ, Donner AP, Maynard M. Prevalence and control of hypertension in an Ontario county. Can Med Assoc J 1985; 132: 1019-1024.
15. Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension prevalence and the status of awareness, treatment, and control in the United States. Hypertension 1985; 7: 457-468.
16. Birkett NJ et al. Hypertension control in two canadian communities: evidence for better treatment and overlabelling. J Hypertens 1986; 4: 369-374.
17. Al-Roomi KA, Heller RF. Blood pressure measurement in an Australian population. Med J Aust 1987; 146: 198-200.
18. Barton SN et al. Comparison of hypertension prevalence and control in 5,237 rural and urban Alabama residents. South Med J 1987; 80: 1220-1223.
19. Dannenberg AL et al. Progress in the battle against hypertension. Hypertension 1987; 10: 226-233.
20. Lang T, Pariente P, Salem G, Tap D. Social, professional conditions and arterial hypertension: an epidemiological study in Dakar, Senegal. J Hypertens 1988; 6: 271-276.
21. Sonkodi S et al. Hypertension screening in a Hungarian town. J Hum Hypertens 1989; 3: 105-110.
22. Bandl E, Boda K, Sonkodi S. Hypertension screening in a dental surgery: a Hungarian study. J Hum Hypertens 1990; 4: 253-257.
23. Bisseliches F, Lanoote M, Moussu C, Montagne C. Hypertension: a survey of 7000 Air France employees. J Hum Hypertens 1990; 4: 326-329.
24. Broda G et al. Adcisnienie tetnicze-wykrywalnosc, leczenie oraaz efetywnoesc leczenia w populacji polskiej objetej programem POL-MONICA. Przeglad Lekarski 1990; 47: 473-478.
25. Tseng WP. Epidemiology of hypertension among Chinese in Taiwan. J Hum Hypertens 1990; 4: 144-146.
26. Baba S et al. Blood pressure levels, related factors, and hypertension control status of Japanese and Americans. J Hum Hypertens 1991; 5: 317-332.
27. Curb JD et al. Cardiovascular risk factor levels in ethnic hawaiians. Am J Public Health 1991; 81: 164-167.
28. Rosolová H, Simon J, Sefrna F. What are the causes of unsatisfactory control of arterial hypertension in the population? Cor Vasa 1991; 33: 301-307.
29. Escamilla-Cejudo JA, López-Cervantes M, Escobedo-De la Peña J, Bastamante-Montes LP. Prevalencia de hipertensión arterial y factores asociados en una delegación poĺtica de la ciudad de México. Arch Inst Cardiol Méx 1992; 62: 267-275.
30. Green MS, Peled I. Prevalence and control of hypertension in a large cohort of occupationally-active Israelis examined during 1985-1987: the Cordis Study. Int J Epidemiol 1992; 21: 676-682.
31. Lyon A, Elefterion A, groupe des médecins du travail du Tarn-et-Garonne, Bousquet H. Prévalence de l'hypertension et de son traitement dans une population de 26 374 travailleurs. Arch Mal Coeur Vaiss 1992; 85: 351-357.
32. Nye ER, Paulin J, Russel DG. Blood pressure in a random sample of the New Zealand population. NZ Med J 1992; 105: 1-3.
33. Stockwell DH et al. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 1994; 84: 1768-1774.
34. Ramirez MOA, Pino CT, Furiasse LVA, Fowkes FGR. Paraguayan National Blood Pressure Study: prevalence of hypertension in the general population. J Hum Hypertens 1995; 9: 891-897.
35. Schmeiser-Rieder A, Kunze U. Blutdruckbewusssein in Österreich: hinweise auf ein zunehmendes informationsdefizit. Wien Klin Wochenschr 1995; 107: 493-499.
36. Entwisle G et al. A survey of blood pressure in the State of Maryland. Prev Med 1983; 12: 695-708.
37. Wagner EH et al. The Edgecombe County high blood pressure control program: I. correlates of uncontrolled hypertension at baseline. Am J Public Health 1984; 74: 237-242.
38. Deprez RD, Miller E, Hart S. Hypertension prevalence among Penobscot Indians of Indian Island, Maine. Am J Public Health 1985; 75: 653-654.
39. Franco LJ et al. Prevalence, detection, and control of hypertension in a biethnic community. The San Antonio Heart Study. Am J Epidemiol 1985; 121: 684-696.
40. M'Buyamba Kabangu JR et al. Epidemiological study of blood pressure and hypertension in a sample of urban Bantu of Zaire. J Hypertens 1986; 4: 485-491.
41. Birkett NJ, Donner AP, Maynard MD. Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance. Can Med Assoc J 1987; 136: 595-600.
42. Nissinen A et al. Ten-year results of hypertension care in the community. Am J Epidemiol 1988; 127: 488-499.
43. Achananuparp S et al. Prevalence, detection and control of hypertension in Thai population of a central rural community. J Med Assoc Thai 1989; 72: 66-75.
44. Jamrozik K, Hockey R. Trends in risk factors for vascular disease in Australia. Med J Aust 1989; 150: 14-18.
45. Salomaa V et al. The development of hypertension care in Finland from 1982 to 1987. J Hypertens 1989; 7: 837-844.
46. Chadha SL et al. Prevalence, awareness & treatment status of hypertension in urban population of Delhi. Indian J Med Res 1990; 92: 233-240.
47. Pica LA, Boucher MM, Grignon R. The prevalence, awareness and control of hypertension in Laval, Quebec, 1986. Can J Public Health 1990; 81: 427-430.
48. Li N et al. Prevalence and medical care of hypertension in four ethnic groups in the newly-industrialised nation of Mauritius. J Hypertens 1991; 9: 859-866.
49. Astagneau P et al. Arterial hypertension in urban Africa: an epidemiological study on a representative sample of Dakar inhabitants in Senegal. J Hypertens 1992; 10: 1095-1101.
50. Joffres MR et al. Prevalence, control and awareness of high blood pressure among Canadian adults. Can Med Assoc J 1992; 146: 1997-2005.
51. Hense HW, Stieber J, Filipiak B, Keil U. Five-year changes in population blood pressure and hypertension prevalence. Results from the MONICA Augsburg surveys 1984/85 and 1989/90. Ann Epidemiol 1993; 3: 410-416.
52. Plans P, Pardell H, Salleras L. Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol 1993; 9: 381-389.
53. Trenkwalder P et al. Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY). J Hypertens 1994; 12: 709-716.
54. Burt VL et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Hypertension 1995; 26: 60-69.
55. Chen CH et al. Epidemiology of hypertension in KinHu Kinmen. Am J Hypertens 1995; 8: 395-403.
56. Ibrahim MM et al. Hypertension prevalence, awareness, treatment and control in Egypt. Hypertension 1995; 26 [part I]: 886-890.
57. Nieto FJ et al. Population awareness and control of hypertension and hypercholesterolemia. Arch Intern Med 1995; 155: 677-684.
58. Tao SQ et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J 1995; 108: 483-489.
59. Vallbona C, Pavlik V. Advances in the community control of hypertension: from epidemiology to primary care practice. J Hypertens 1992; 10: S51-S57.
60. Lenfant C, Roccella EJ. Overview, the fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Cardiovasc Risk Factors 1994; 4: 123-12126.
61. WHO MONICA Project. WHO MONICA Project: objectives and design. Int J Epidemiol 1989; 19: 529-537.
62. Strasser T. Relative costs of antihypertensive drug treatment. J Hum Hypertens 1992; 2: 489-494.
63. Drummond M, Coyle D. Assessing the economic value of antihypertensive medicines. J Hum Hypertens 1992; 2: 495-501.
64. Ménard J, Cornu P, Day M. Cost of hypertension treatment and the price of health. J Hum Hypertens 1992; 6: 447-458.
65. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-721.
66. Stason WB. Cost and quality trade-offs in the treatment of hypertension. Hypertension 1989; 13: I145-I148.
67. Kawachi I, Malcolm LA. Treating mild to moderate hypertension: cost-effectiveness and policy implications. J Cardiovasc Pharmacol 1990; 16: S126-S128.
68. Puska P, Neittaanmäki L, Tuomilehto J. A survey of local health personnel and decision makers concerning the North Karelia Project: a community program for control of cardiovascular diseases. Prev Med 1981; 10: 564-576.
69. Ménard J, Chatellier G. Limiting factors in the control of BP: why is there a gap between theory and practice? J Hum Hypertens 1995; 9: 519-523.
70. Hosie J, Wiklund I. Managing hypertension in general practice: can we do better? J Hum Hypertens 1995; 9: 515-518.
71. Vezù L, La Vecchia L, Vincenzi M. Hypertension, obesity and response to antihypertensive treatment: results of a community survey. J Hum Hypertens 1992; 6: 215-220.
72. Tuomilehto J, Enlund H, Salonen J, Nissinen A. Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med 1984; 12: 177-181.
73. Lang T et al. Relations between alcohol consumption and hypertension prevalence and control in a French population. J Chron Dis 1987; 40: 713-720.
74. O'Brien E, Mee F, Atkins N, O'Malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 1990; 336: 1465-1468.
75. Conroy RM, O'Brien E, O'Malley K, Atkins N. Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? Br Med J 1993; 306: 1319-1322.
76. WHO MONICA Project (prepared by Hense et al). Quality assessment of blood pressure measurements in epidemiological surveys. The impact of last digit preference and the proportions of identical duplicate measurements. Rev Epidémiol Santé Publ 1990; 38: 463-468.
77. Canner PL et al. The Hypertension Prevention Trial: assessment of the quality of blood pressure measurements. Am J Epidemiol 1991; 134: 379-392.
78. Alderman MH. Non-pharmacological treatment of hypertension. Lancet 1994; 344: 307-311.